Literature DB >> 9490274

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.

L Nakopoulou1, C Vourlakou, A Zervas, A Tzonou, H Gakiopoulou, M A Dimopoulos.   

Abstract

The aim of this study was to investigate the expression of bcl-2, p53 oncoproteins, and Ki-67 antigen in a series of transitional cell bladder carcinomas and its relation to the traditional prognostic indicators and patient's survival. One hundred six cases with transitional cell carcinoma (TCC) were examined for detection of bcl-2, p53 proteins, and Ki-67 antigen (MIB1 antibody). Bcl-2 immunohistochemical positivity was observed in 52% of TCCs and in 57% of low-grade and 44% of high-grade TCCs. Bcl-2 was also detected in normal urothelium and dysplastic lesions with basal cell expression, and negative staining was observed in carcinomas in situ. Tumor stage showed a significant inverse correlation with overall bcl-2 positivity. The loss of bcl-2 protein expression in higher-stage TCCs was statistically significant (Pt = .01). p53 protein was overexpressed in 50% of TCCs and more frequently in invasive and in carcinomas in situ than in superficial TCCs (Pt = .03). In contrast, detection of p53 was not observed in normal and dysplastic urothelium. p53 positivity was related to the degree of differentiation and to the stage of the disease (Pf = .01 and Pt = .03, respectively). Concerning Ki-67 antigen, its expression was found in 57.5% of TCCs. There was a strong overall correlation of Ki-67 with tumor stage (Pt = .002) and grade (Pf = .002). Univariate statistical analysis showed that the expression of p53 and Ki-67 was significantly correlated to poor prognosis (P = .02, P = .02, respectively). On multivariate analysis, none of these markers but only stage and grade were significantly correlated to prognosis (P = .02, P = .02, respectively). These findings suggest that overexpression of bcl-2 protein may be an early event in tumorigenesis. Tumors with loss of bcl-2 positivity and overexpression of p53 and Ki-67 had an unfavorable prognosis; however, in multivariate analysis, they had no independent prognostic value.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490274     DOI: 10.1016/s0046-8177(98)90225-8

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  16 in total

1.  Predictive value of topoisomerase II alpha immunostaining in urothelial bladder carcinoma.

Authors:  L Nakopoulou; A Zervas; A C Lazaris; C Constantinides; C Stravodimos; P Davaris; C Dimopoulos
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

2.  Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma.

Authors:  Saba El-Gendi; Ghada Abu-Sheasha
Journal:  Pathol Oncol Res       Date:  2017-05-09       Impact factor: 3.201

3.  The significance of p53 and bcl-2 overexpression and other prognostic factors in transitional cell carcinoma of the bladder.

Authors:  Stavros Touloupidis; Georgios Fatles; Christos Kalaitzis; Alexandra Giatromanolaki; Eythimyos Sivridis; Konstantinos Simopoulos; Vassilios Rombis
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

4.  Detection of bcl-2 and bax expression and bcl-2/JH fusion gene in intrahepatic cholangiocarcinoma.

Authors:  Lin-Lang Guo; Sha Xiao; Ying Guo
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

5.  The expression of bcl-2 and bcl-6 protein in normal and malignant transitional epithelium.

Authors:  Zhenhua Lin; Hankyeom Kim; Hongseok Park; Youngsik Kim; Jun Cheon; Insun Kim
Journal:  Urol Res       Date:  2003-07-16

6.  AgNOR/P53 expression compared with different grades in bladder carcinoma.

Authors:  M Karakök; A Aydin; K Bakir; R Uçak; C Korkmaz
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

7.  Spotlight on differentially expressed genes in urinary bladder cancer.

Authors:  Apostolos Zaravinos; George I Lambrou; Dimitrios Volanis; Dimitris Delakas; Demetrios A Spandidos
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

8.  Altered expression of cellular Bcl-2 in the progression of hamster cholangiocarcinogenesis.

Authors:  Byung-Suk Jeon; Byung-Il Yoon
Journal:  ScientificWorldJournal       Date:  2012-04-30

9.  Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.

Authors:  Ahmed S Abdulamir; Rand R Hafidh; Haider S Kadhim; Fatimah Abubakar
Journal:  J Exp Clin Cancer Res       Date:  2009-02-25

10.  The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis.

Authors:  Antoine G van der Heijden; Christina A Hulsbergen-Van de Kaa; J Alfred Witjes
Journal:  World J Urol       Date:  2007-02-14       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.